Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Enliven Therapeutics, Inc. - Common Stock (NQ:ELVN)

59.65 +0.64 (+1.08%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 3, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	806,070
Open	58.88
Bid (Size)	59.52 (500)
Ask (Size)	59.65 (5,500)
Prev. Close	59.01
Today's Range	58.66 - 60.10
52wk Range	14.79 - 62.32
Shares Outstanding	41,151,111
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

What to Know About This $345,000 Enliven Insider Sale as the Stock Soars 130% ↗

June 27, 2026

This Boulder biotech advancing cancer drugs saw a notable insider sale amid strong 1-year stock gains and early clinical progress.

Via The Motley Fool

What to Know About OrbiMed's $39 Million Enliven Therapeutics Stock Sale Amid a 130% Rally ↗

June 27, 2026

Focused on cancer therapies, this Boulder-based biotech reported significant insider selling amid a year of sharp share price gains.

Via The Motley Fool

Performance

YTD	+283.8%	+283.8%
1 Month	-2.4%	-2.4%
3 Month	+68.1%	+68.1%
6 Month	+103.7%	+103.7%
1 Year	+184.7%	+184.7%

More News

Medical Hedge Fund Sells 281,000 Shares of Enliven Theapeutics. Is it Time to Sell ELVN? ↗

June 24, 2026

Via The Motley Fool

Enliven Therapeutics' Chief Medical Officer Sold 5,000 Company Shares. Here's What That Means for Investors. ↗

June 01, 2026

Via The Motley Fool

This $5.5 Million Exit Raises Questions After Wave Life Sciences' Rough First Quarter ↗

May 31, 2026

Via The Motley Fool

Why This Biotech Fund Added $7 Million to an Oncology Stock Up 120% ↗

May 13, 2026

Via The Motley Fool

Why This Biotech Fund Opened a $9 Million Position in a Newly Public Cancer Company ↗

May 13, 2026

Via The Motley Fool

Why This Biotech Fund Increased Its Oruka Therapeutics Stake Amid a Staggering 500% Rally ↗

May 13, 2026

Via The Motley Fool

Enliven Theraeutics' (ELVN) Chief Medical Officer Sold 40,000 Shares for $1.2 Million ↗

March 28, 2026

Via The Motley Fool

Enliven Therapeutics Chief Scientific Officer Sells ELVN 20K Shares Worth Over $500k ↗

February 01, 2026

Via The Motley Fool

The $225B Precision Sprint: How Big Pharma is Beating the $170B Patent Cliff

January 12, 2026

From Equity Insider

Via GlobeNewswire

S&P 500, Nasdaq Futures Waver Ahead Of Supreme Court Ruling On Trump Tariffs: Why OPEN, ACON, FLYX, OSCR Are Trending After-Hours ↗

January 08, 2026

Via Stocktwits

Here are the top movers in Thursday's session. ↗

January 08, 2026

Via Chartmill

ELVN Stock Shot Up 60% Today – What’s Driving The Rally? ↗

January 08, 2026

Via Stocktwits

These stocks are gapping in today's session ↗

January 08, 2026

Via Chartmill

Resemble AI Unleashes Chatterbox Turbo: A New Era for Open-Source Real-Time Voice AI

December 15, 2025

Via TokenRing AI

With a 150% Rally and Big 2026 Catalysts Ahead, Is Amylyx Stock Getting a Second Chance? ↗

December 03, 2025

Via The Motley Fool

Scholar Rock Stock Is Still Down 40% From 2021 Highs — And One Investor Just Walked Away ↗

December 03, 2025

Via The Motley Fool

Terns Stock Surges 300% in One Year — What a New $43 Million Position Signals for Investors ↗

December 03, 2025

Via The Motley Fool

Relay Therapeutics Stock Has Jumped 60% in a Year — And One Investor Just Bought Nearly 4 Million More Shares ↗

December 03, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 03, 2025

Via Benzinga

What's going on in today's pre-market session ↗

August 15, 2025

Via Chartmill

Enliven Posts Loss Beat and Cash Surge ↗

August 13, 2025

Via The Motley Fool

Meta To Rally Around 3%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

July 02, 2025

Via Benzinga

Enliven Short Interest Falls To 14-Month Low After Leukemia Trial Data, Goldman Initiates With ‘Buy’ ↗

June 23, 2025

Via Stocktwits

Frequently Asked Questions

Is Enliven Therapeutics, Inc. - Common Stock publicly traded?

Yes, Enliven Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Enliven Therapeutics, Inc. - Common Stock trade on?

Enliven Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Enliven Therapeutics, Inc. - Common Stock?

The ticker symbol for Enliven Therapeutics, Inc. - Common Stock is ELVN on the Nasdaq Stock Market

What is the current price of Enliven Therapeutics, Inc. - Common Stock?

The current price of Enliven Therapeutics, Inc. - Common Stock is 59.65

When was Enliven Therapeutics, Inc. - Common Stock last traded?

The last trade of Enliven Therapeutics, Inc. - Common Stock was at 09/03/26 04:00 PM ET

What is the market capitalization of Enliven Therapeutics, Inc. - Common Stock?

The market capitalization of Enliven Therapeutics, Inc. - Common Stock is 2.45B

How many shares of Enliven Therapeutics, Inc. - Common Stock are outstanding?

Enliven Therapeutics, Inc. - Common Stock has 2B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.